Table 3 Definition of regional lymph node (N)

From: Melanoma pathology reporting and staging

 

Extent of regional lymph node and/or lymphatic metastasis

N Category

Number of tumor-involved regional lymph node

Presence of in-transit, satellite, and/or microsatellite metastases

NX

Regional nodes not assessed (e.g., SLN biopsy not performed, regional nodes previously removed for another reason)

Exception: pathological N category is not required for T1 melanomas, use cN, if regional lymph nodes not assessed for patient with T1 melanoma

No

N0

No regional metastases detected

No

N1

One tumor-involved node or any number of in-transit, satellite, and/or microsatellite metastases with no tumor-involved nodes

 

 N1a

One clinically occult (i.e., detected by SLN biopsy)

No

 N1b

One clinically detected

No

 N1c

No regional lymph node disease

Yes

N2

Two or three tumor-involved nodes or any number of in-transit, satellite, and/or microsatellite metastases with one tumor-involved node

 

 N2a

Two or three clinically occult (i.e., detected by SLN biopsy)

No

 N2b

Two or three, at least one of which was clinically detected

No

 N2c

One clinically occult or clinically detected

Yes

N3

Four or more tumor-involved nodes or any number of in-transit, satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases

 

 N3a

Four or more clinically occult (i.e., detected by SLN biopsy)

No

 N3b

Four or more, at least one of which was clinically detected, or presence of any number of matted nodes

No

 N3c

Two or more clinically occult or clinically detected and/or presence of any number of matted nodes

Yes

  1. Adapted with permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original and primary source for this information is the AJCC Cancer Staging Manual, 8th edition (2017) published by Springer International Publishing
  2. Modified from ref. [24]